Belgium· BE-AMP-SAM181632-00
Atenolol Teva 50 mg
A atenolol product containing atenolol, registered in Belgium by Teva. The same ATC class is registered in 17 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Atenolol is registered in 17 of 19 countries.
Countries holding a registration under ATC C07AB03 (atenolol), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 9 of them publish a price we can compare per daily dose
Atenolol · ATC C07AB03
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of atenolol costs, country by country.
Normalised to the WHO defined daily dose (75 mg), the median price runs from $0.11 in Italy to $0.58 in Switzerland — a ×5.2 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Atenolol · price per daily dose (75 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.58
- FR France$0.12
- IT Italy$0.11
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Atenolol
- Manufacturer
- Teva
- Country
- Belgium (BE)
- ATC code
- C07AB03
- ATC class
- Atenolol
- Defined daily dose
- 75 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 3
2 priced- be_apb1373356EUR 10.77
- be_apb1378827EUR 12.73
- be_apb0747147
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
428 interactions on record for atenolol.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Atenolol · interactions on record
428 records
- 11 severe
- 181 moderate
- 20 minor
- 174 info
Most severe, free to view
- DolasetronA04AA04severe
- TheophyllinC01EB28severe
- CeritinibL01ED02severe
- CeritinibL01XE28severe
42 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C07AB03
Atenolol, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e08b65e6-5ace-4931-b73f-caecff2474af GET /v1/drugs/e08b65e6-5ace-4931-b73f-caecff2474af?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Atenolol Teva 50 mg",
"name_fr": "Atenolol Teva 50 mg",
"name_nl": "Atenolol Teva 50 mg",
"amp_code": "SAM181632-00",
"strengths": [
"50.0000",
"50.0000",
"9.0000",
"9.0000"
],
"pack_count": 3,
"substances": [
"Atenolol",
"Sodium Starch Glycolate (Type A)"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Atenolol",
"authorisation_numbers": [
"BE181632"
]
}See everything about atenolol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.